findmyKOL

Benjamin Romer, MD

Basic profile

The Ohio State University Wexner Medical Center

ORCIDNone on fileNPI
RegionGahanna, OH · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Benjamin Romer is a Cardiology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 8 publications with 406 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Distinct works indexed by OpenAlex.

406citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

920 N Hamilton Rd
Gahanna, OH 432301757

Telephone

614-293-7677

Provider last certified this registry record 16 Dec 2020.

View the NPPES registry record

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    83.8%
    Beta blocker19.2%
    Metoprolol Succinate51%Carvedilol39%Metoprolol Tartrate10%
    Part D79 patients
    Statin13.7%
    Atorvastatin Calcium66%Rosuvastatin Calcium34%
    Part D70 patients

    + 15 more classes in this area

  • Blood & clotting

    10.1%
    Factor Xa inhibitor8.6%
    Eliquis67%Xarelto33%
    Part D38 patients
    P2Y12 inhibitor1.5%
    Clopidogrel100%
    Part D15 patients
  • Metabolism & gastrointestinal

    6%
    SGLT2 inhibitor5.2%
    Jardiance63%Farxiga38%
    Part D<11 patients
    Potassium supplement0.9%
    Potassium Chloride52%Klor-Con M2048%
    Part D<11 patients
Where care is delivered (Part B)35.7% facility · 64.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”